A carregar...
Inhibition of phospholipase D2 augments histone deacetylase inhibitor-induced cell death in breast cancer cells
BACKGROUND: Histone deacetylase (HDAC) inhibitors are promising anticancer drugs but their effect on tumor treatment has been disappointing mainly due to the acquisition of HDAC inhibitor resistance. However, the mechanisms underlying such resistance remain unclear. METHODS: In this study, we perfor...
Na minha lista:
| Publicado no: | Biol Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7528251/ https://ncbi.nlm.nih.gov/pubmed/32998768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40659-020-00294-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|